MarkMeterskyMD

Pulmonology • Farmington, CT

Critical Care Medicine, Infectious Disease, Pleural Disease

Professor, University of Connecticut School of Medicine

Join to view full profile

Dr. Metersky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Metersky's full profile

Already have an account?

Office
263 Farmington Ave
Farmington, CT 06030
Phone+1 860-679-3343

Fax+1 860-679-4256

Education & Training

University of California (San Diego) Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1989 - 1992
Boston University Medical CenterResidency, Internal Medicine, 1985 - 1988
New York University School of MedicineClass of 1985

Certifications & Licensure

CA State Medical License 1989 - Present
CT State Medical License 1992 - 2025
FL State Medical License 2020 - 2022
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2002-2014
Top MD Consumers Checkbook

Clinical Trials

Scleroderma Lung Disease Start of enrollment: 1999 Aug 01
Completed
Phase 3
Bosentan for Poorly Controlled Asthma Start of enrollment: 2008 Dec 01
Terminated
Phase 2

Publications & Presentations

PubMed

Respiratory syncytial virus pulmonary infections in adults - disease burden and prevention.
Grant W Waterer, Mark Metersky
Current Opinion in Pulmonary Medicine. 2025-05-01
Evolution of Esophageal Adenocarcinoma from Precursor Lesion Stem Cells.
Wa Xian, Shan Wang, Jingzhong Xie, Yusuke Yamamoto, Melina Khorrami
Gastroenterology. 2025-03-14
Brensocatib in patients with bronchiectasis: subgroup analyses from the WILLOW trial.
James D Chalmers, Michael R Loebinger, Ariel Teper, Pamela J McShane, Carlos Fernandez
ERJ Open Research. 2025-01-01

Journal Articles

Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
Mark L Metersky, Charles L Daley, The New England Journal of Medicine
Association Between Medicare Expenditures and Adverse Events for Patients with Acute Myocardial Infarction, Heart Failure, or Pneumonia in the United States
Mark L Metersky, Harlan M Krumholz, JAMA Network Open
Case Report Bordetella Bronchiseptica in Non-Cystic Fibrosis Bronchiectasis
Vanessa L Yap, Elham Karamooz, Mark L Metersky, Alan F Barker, ScienceDirect

Authored Content

Trend in Ventilator-Associated Pneumonia Rates Between 2005 and 2013November 2016
Trend in Ventilator-Associated Pneumonia Rates Between 2005 and 2013November 2016

Press Mentions

CT Still Feeling Stress of Influenza and Other Respiratory Ailments as Winter Drags OnFebruary 25th, 2025
What to Know About Pneumonia as Pope Francis Is HospitalizedFebruary 20th, 2025
COVID-19 Burden in Hospitals Affects Risk for in-Hospital Adverse EventsNovember 8th, 2024
Join now to see all

Grant Support

Obstacles To Usage Of The Pneumoccocal VaccineNational Center For Research Resources1998–1999
Compliance With Tuberculosis Prophylaxis After Release For Correctional FacilityNational Center For Research Resources1998–1999